![](/wp-content/uploads/2019/06/fenix-group-announcement.png)
$599
Xeris Glucagon Filing Accepted by FDA; June 10, 2019 PDUFA
Xeris Pharmaceuticals announced FDA has accepted the NDA filing for its stable glucagon with a PDUFA date on Monday, June 10, 2019, the Monday of ADA. This confirms FENIX’s previous belief that Xeris’s stable glucagon would have a 10-month review period. Below, FENIX provides thoughts on Xeris’s later-than-anticipated regulatory submission and impending market dynamics in the glucagon rescue market.